BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3410802)

  • 1. Pharmacokinetics of cefixime in the young and elderly.
    Faulkner RD; Bohaychuk W; Lanc RA; Haynes JD; Desjardins RE; Yacobi A; Silber BM
    J Antimicrob Chemother; 1988 Jun; 21(6):787-94. PubMed ID: 3410802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between renal function and disposition of oral cefixime.
    Dhib M; Moulin B; Leroy A; Hameau B; Godin M; Johannides R; Fillastre JP
    Eur J Clin Pharmacol; 1991; 41(6):579-83. PubMed ID: 1815970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic properties of cefixime].
    Barré J
    Presse Med; 1989 Oct; 18(32):1578-82. PubMed ID: 2530536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of cefixime in the fasted and fed state.
    Faulkner RD; Bohaychuk W; Haynes JD; Desjardins RE; Yacobi A; Silber BM
    Eur J Clin Pharmacol; 1988; 34(5):525-8. PubMed ID: 3203716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalency of oral suspension formulations of cefixime.
    Faulkner RD; Sia LL; Barone JS; Forbes SJ; Silber BM
    Biopharm Drug Dispos; 1989; 10(2):205-11. PubMed ID: 2706319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
    Mamzoridi K; Kasteridou N; Peonides A; Niopas I
    Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state.
    Faulkner RD; Bohaychuk W; Desjardins RE; Look ZM; Haynes JD; Weiss AI; Silber BM
    J Clin Pharmacol; 1987 Oct; 27(10):807-12. PubMed ID: 3429686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of cefixime in man.
    Faulkner RD; Yacobi A; Barone JS; Kaplan SA; Silber BM
    Pediatr Infect Dis J; 1987 Oct; 6(10):963-70. PubMed ID: 3696837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute bioavailability of cefixime in man.
    Faulkner RD; Fernandez P; Lawrence G; Sia LL; Falkowski AJ; Weiss AI; Yacobi A; Silber BM
    J Clin Pharmacol; 1988 Aug; 28(8):700-6. PubMed ID: 3216036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].
    Montay G; Le Liboux A; Thebault JJ; Roche G; Frydman A; Gaillot J
    Presse Med; 1989 Oct; 18(32):1583-6. PubMed ID: 2530537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
    Kees F; Naber KG
    Infection; 1990; 18 Suppl 3():S150-4. PubMed ID: 2079377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
    Bialer M; Batra VK; Morrison JA; Silber BM; Look ZM; Yacobi A
    Pharm Res; 1987 Feb; 4(1):33-7. PubMed ID: 3508527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hepatic failure upon the pharmacokinetics of cefixime].
    Singlas E; Lebrec D; Gaudin C; Montay G; Roche G; Taburet AM
    Presse Med; 1989 Oct; 18(32):1587-8. PubMed ID: 2530538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacologic aspects of cefixime in dogs.
    Lavy E; Ziv G; Aroch I; Glickman A
    Am J Vet Res; 1995 May; 56(5):633-8. PubMed ID: 7661460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative bioavailability of three cefixime formulations.
    Kees F; Naber KG; Sigl G; Ungethüm W; Grobecker H
    Arzneimittelforschung; 1990 Mar; 40(3):293-7. PubMed ID: 2346538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
    Montay G; Masala F; Le Roux Y; Le Liboux A; Uhlrich J; Chassard D; Thebault JJ; Roche G; Frydman A
    Drugs; 1991; 42 Suppl 4():6-9. PubMed ID: 1725153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biliary excretion and hepatic disposal of cefixime: experimental and clinical study].
    Westphal JF; Brogard JM; Jehl F; Blickle JF; Dorner M; Monteil H
    Pathol Biol (Paris); 1992 May; 40(5):538-44. PubMed ID: 1495841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic studies on oral antibiotics in pediatrics. I. A pharmacokinetic study on cefixime in pediatrics].
    Nakamura H; Iwai N
    Jpn J Antibiot; 1991 Sep; 44(9):964-78. PubMed ID: 1960858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.